Market Analysis: Asia-Pacific Biopsy Devices Market
Market Definition: Asia-Pacific Biopsy Devices Market
Biopsy is a medical test conducted to evaluate and eliminate the body's cancer tissue. Biopsy is often used to obtain tissue sample to diagnose the disease when a patient is presumed of having cancer. There are different kinds of biopsy used in cancer diagnosis, including skin biopsy, fine needle aspiration, vacuum biopsy, shave biopsy, incision and excision biopsy, and needle biopsy. In needles, mechanical biopsy devices and biopsy guides, along with technological advances in significant computed tomography (CT) and ultrasonography (US) imaging techniques, there have been constant improvements.
Get More Insights About Asia-PacificBiopsy DevicesMarket, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-biopsy-devices-market
Increasing incidents of cancer, is driving the growth of the market
Increasing government initiatives, is helping in the growth of the market
Surging demand for minimally invasive surgeries, are the major factor for the growth of the market
Technological advancement in the field of biopsy devices, drives the market growth
Strict standards and regulation for the use of biopsy, hinders the growth of the market
Expensive biopsy devices, also restricts the growth of the market
Increasing complaints to breast cancer screening procedure, impeding growth of the market
Segmentation: Asia-Pacific Biopsy Devices Market
Needle-Based Biopsy Instruments
Core Biopsy Devices
Aspiration Biopsy Needles
Vacuum-Assisted Biopsy Devices
By Guidance Technique
Other Guidance Techniques
By End User
Academic and Research Institutes
Diagnostic and Imaging Centers
Rest of Asia-Pacific
Know more about this report https://www.databridgemarketresearch.com/reports/asia-pacific-biopsy-devices-market
Key Developments in the Market:
In May 2019, FUJIFILM Corporation today announced that it has entered into an arrangement to purchase medwork GmbH, a firm that creates and sells tools for therapy and diagnostic endoscopy. Medwork creates, produces and sells in-house endoscopic tools. The firm offers a high quality of its products used in endoscopic procedures for bile ducts, pancreatic ducts and digestive tracts and a broad variety of apps including lithotrite, polypectomy and biopsy*, which are spread in Europe and Asia, including Japan.
In January 2019, MobileODT, the maker of the Enhanced Visual Assessment (EVA) scheme, will work with Apollo Hospitals and Genworks to provide their FDA-cleared, mobile, smart colposcope. The project will implement the first large-scale Augmented Intelligence (AI) engine for use in the cervical cancer screening. This implementation will provide healthcare professionals with cutting-edge, yet a low-cost mobile technology connectivity to millions of women across the Indian subcontinent which previously had limited access to the life-saving cervical exams.
Key Market Competitors:
Few of the major market competitors currently working in the Asia-Pacific biopsy devices market are BD, Devicor Medical Products, Inc., ARGON MEDICAL., SOMATEX Medical Technologies GmbH, , Scion Medical Technologies, LLC, STERYLAB S.r.l., EndoMed Systems Alle Rechte vorbehalten, TSK Laboratory Asia PacificB.V., B. Braun Melsungen AG, Cardinal Health, Siemens, General Electric Company, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Olympus Corporation, Medtronic, SRL Diagnostics among others.
Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-biopsy-devices-market
Browse Trending Related Reports @
About Data Bridge Market Research: